Previous close | 0.0355 |
Open | 0.0330 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 1100 |
Day's range | 0.0330 - 0.0413 |
52-week range | 0.0210 - 0.3295 |
Volume | |
Avg. volume | 116,639 |
Market cap | 4.003M |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2000 |
Earnings date | 28 Mar 2024 - 30 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
COLUMBUS, Ohio, January 27, 2024--Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
DUBLIN, Ohio, December 01, 2023--Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
DUBLIN, Ohio, October 06, 2023--Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock